Articles

Podcasts

Videos

Dermatology

The HCPLive dermatology page is a resource for medical news and expert insights on skin disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for dermatologic conditions, and more.

Dr. Hawryluk noted that acne is estimated to affect 35%-95% of pediatric patients worldwide, though proper diagnosis and treatment of this dermatological condition is possible.

Elena B. Hawryluk, MD, PhD: Detailing Acne Vulgaris Management

Studies are needed to determine the best treatment regimen for these patients.

Women with Acne Commonly Experience Depression and Social Isolation

Treatment was associated with reductions in IGA scores as well as inflammatory and non-inflammatory lesion counts.

FDA Approves Tretinoin and Benzoyl Peroxide Cream for Acne Vulgaris

All patients treated with 2.5 benzoyl peroxide and a stabilized cosmetic retinol saw significant improvement in lesion count reduction after 12 weeks. 

Benzoyl Peroxide Plus Retinol Regimen Highly Efficacious for Acne Vulgaris 

Patients with acne who receive isotretinoin treatment can expect a four- to five-fold improvement from baseline to follow-up in quality of life.

Isotretinoin Improves Quality of Life for Patients With Acne

A dermatologist and clinical associate professor of dermatology discusses implementing telehealth in dermatology practices.

Julie Harper, MD: How Our Dermatology Practice is Using Telemedicine

The new topical lotion is aimed at treating patients at least 9 years old with acne vulgaris.

FDA Approves New Treatment for Acne Vulgaris

AKLIEF Cream, a topical cream to treat acne on the face and trunk, is expected to be available in the US in November.

FDA Approves New Topical Cream to Treat Acne

The HCPLive acne page is a resource for medical news and expert insights on dermatological disease. This page features expert-led coverage, articles, videos, and research on the therapies and development of treatments for chronic acne, and more.